The biotechnology scene in Asia is rapidly growing and has become a major player in the biotech industry globally. And in recent years, Singapore has also become a hub for biomedical startups.
Vishal Doshi, Chairman & CEO, AUM Biosciences shares how he is paving the way for disruption in Asia’s biotech landscape and oncology drug space.